LDL Apheresis or PCSK9 Inhibition? Sometimes We Have to Combine Them

Vessel Plus
doi 10.20517/2574-1209.2017.08
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OAE Publishing Inc.

Related search

Acute Stroke: We Have the Treatments and We Have the Evidence – We Need to Use Them

Critical Care
Critical CareIntensive Care Medicine
2007English

Development of Selective LDL Adsorbent and LDL Apheresis System: Immobilized Polyanion as LDL-Specific Adsorbent for LDL Apheresis System

The Journal of Japan Atherosclerosis Society
1990English

Controlling Hypertension: We Have the Tools—We Just Need to Use Them

Journal of General Internal Medicine
Internal Medicine
2017English

LDL-Apheresis: Technical and Clinical Aspects

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2012English

PReS13-SPK-1028: Activity and Damage - We Have to Measure Them

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

Hedge Fund Return Predictability; To Combine Forecasts or Combine Information?

Journal of Banking and Finance
EconomicsEconometricsFinance
2015English

The Schools We Need and Why We Don’t Have Them, by E.D. Hirsch, Jr.

Journal of Catholic Education
2005English

To Wrap or Not to Wrap – Have We Now Come Full Circle?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Cell-Associated, Heparin-Like Molecules Modulate the Ability of LDL to Regulate PCSK9 Uptake

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy